U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Gastric Carcinoma

MedGen UID:
75828
•Concept ID:
C0278502
•
Neoplastic Process
Synonyms: Gastric Carcinoma, Recurrent; Recurrent Cancer of Stomach; Recurrent Cancer of the Stomach; Recurrent Carcinoma of Stomach; Recurrent Carcinoma of the Stomach; Recurrent Gastric Cancer; Recurrent Stomach Cancer; Recurrent Stomach Carcinoma

Definition

The reemergence of gastric carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Gastric Carcinoma

Professional guidelines

PubMed

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Kim WK, Lee JS, Kang YK
Jpn J Clin Oncol 2007 Jan;37(1):30-7. doi: 10.1093/jjco/hyl134. PMID: 17272321
Use of stents in the palliative treatment of malignant gastric outlet and duodenal obstruction.
Aviv RI, Shyamalan G, Khan FH, Watkinson AF, Tibballs J, Caplin M, Winslett M
Clin Radiol 2002 Jul;57(7):587-92. doi: 10.1053/crad.2002.0934. PMID: 12096856

Recent clinical studies

Etiology

Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.
Liu S, Zhao Z, Han L, Liu S, Luo B
PLoS One 2016;11(2):e0148342. Epub 2016 Feb 9 doi: 10.1371/journal.pone.0148342. PMID: 26859565Free PMC Article
Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S
Cancer 2000 Jul 15;89(2):255-61. doi: 10.1002/1097-0142(20000715)89:2<255::aid-cncr8>3.0.co;2-n. PMID: 10918153
A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A 3rd
Cancer 1999 Jan 15;85(2):290-4. PMID: 10023694
5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T, Wiechowska-Kozlowska A, Marlicz K, Bromley M, Roberts SA, Lawniczak M, Kolodziej B, Zyluk A, Stern PL
Eur J Gastroenterol Hepatol 1998 Jun;10(6):479-84. doi: 10.1097/00042737-199806000-00008. PMID: 9855063
Esophageal carcinoma simultaneously associated with gastric carcinoma: analysis of clinicopathologic features and treatments.
Kato H, Tachimori Y, Watanabe H, Mizobuchi S, Igaki H, Yamaguchi H, Ochiai A
J Surg Oncol 1994 Jun;56(2):122-7. doi: 10.1002/jso.2930560216. PMID: 8007677

Diagnosis

A case of non-specific interstitial pneumonia with recurrent gastric carcinoma and anti-Jo-1 antibody positive myositis.
Ebisutani C, Ito I, Kitaichi M, Tanabe N, Mishima M, Kadowaki S
Respir Investig 2016 Jul;54(4):289-93. Epub 2016 Mar 17 doi: 10.1016/j.resinv.2016.02.005. PMID: 27424830
Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed.
Watanabe M, Suzuki H, Maejima K, Komine O, Mizutani S, Yoshino M, Bo H, Kitayama Y, Uchida E
Med Sci Monit 2012 Jul;18(7):CS53-6. doi: 10.12659/msm.883196. PMID: 22739738Free PMC Article
5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T, Wiechowska-Kozlowska A, Marlicz K, Bromley M, Roberts SA, Lawniczak M, Kolodziej B, Zyluk A, Stern PL
Eur J Gastroenterol Hepatol 1998 Jun;10(6):479-84. doi: 10.1097/00042737-199806000-00008. PMID: 9855063
Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma.
Korenaga D, Saeki H, Mawatari K, Orita H, Maekawa S, Ikeda T, Sugimachi K
Arch Surg 1997 Feb;132(2):188-94. doi: 10.1001/archsurg.1997.01430260086019. PMID: 9041925
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Casaldi V, Cavaliere F, Carlini M, Garofalo A, Rinaldi G
Anticancer Res 1993 Nov-Dec;13(6B):2409-13. PMID: 8135475

Therapy

Hyperthermia improves immune function and radiotherapy efficacy in patients with post-operative recurrent gastric cancer.
Lyu X, Zheng D, Zhang H, Zhang T, Han N, Zhang M, Dong Z
Hepatogastroenterology 2014 Nov-Dec;61(136):2428-33. PMID: 25699397
Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301).
Komatsu Y, Takahashi Y, Kimura Y, Oda H, Tajima Y, Tamura S, Sakurai J, Wakasugi T, Tatebe S, Takahashi M, Sakata Y, Kitajima M, Sakamoto J, Saji S
Anticancer Drugs 2011 Jul;22(6):576-83. doi: 10.1097/CAD.0b013e328345b509. PMID: 21512394
A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y
Hepatogastroenterology 2003 Nov-Dec;50(54):2259-63. PMID: 14696512
Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R, Tanabe K, Inoue H, Toge T
Int J Oncol 2002 Mar;20(3):549-55. PMID: 11836567
A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A 3rd
Cancer 1999 Jan 15;85(2):290-4. PMID: 10023694

Prognosis

Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions.
Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, Suzuki S, Kawamura M, Kumagai K, Kusano M
Br J Cancer 2004 Oct 4;91(7):1342-8. doi: 10.1038/sj.bjc.6602147. PMID: 15354218Free PMC Article
A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y
Hepatogastroenterology 2003 Nov-Dec;50(54):2259-63. PMID: 14696512
Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S
Cancer 2000 Jul 15;89(2):255-61. doi: 10.1002/1097-0142(20000715)89:2<255::aid-cncr8>3.0.co;2-n. PMID: 10918153
5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T, Wiechowska-Kozlowska A, Marlicz K, Bromley M, Roberts SA, Lawniczak M, Kolodziej B, Zyluk A, Stern PL
Eur J Gastroenterol Hepatol 1998 Jun;10(6):479-84. doi: 10.1097/00042737-199806000-00008. PMID: 9855063
Esophageal carcinoma simultaneously associated with gastric carcinoma: analysis of clinicopathologic features and treatments.
Kato H, Tachimori Y, Watanabe H, Mizobuchi S, Igaki H, Yamaguchi H, Ochiai A
J Surg Oncol 1994 Jun;56(2):122-7. doi: 10.1002/jso.2930560216. PMID: 8007677

Clinical prediction guides

Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions.
Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, Suzuki S, Kawamura M, Kumagai K, Kusano M
Br J Cancer 2004 Oct 4;91(7):1342-8. doi: 10.1038/sj.bjc.6602147. PMID: 15354218Free PMC Article
A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y
Hepatogastroenterology 2003 Nov-Dec;50(54):2259-63. PMID: 14696512
Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R, Tanabe K, Inoue H, Toge T
Int J Oncol 2002 Mar;20(3):549-55. PMID: 11836567
Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S
Cancer 2000 Jul 15;89(2):255-61. doi: 10.1002/1097-0142(20000715)89:2<255::aid-cncr8>3.0.co;2-n. PMID: 10918153
5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T, Wiechowska-Kozlowska A, Marlicz K, Bromley M, Roberts SA, Lawniczak M, Kolodziej B, Zyluk A, Stern PL
Eur J Gastroenterol Hepatol 1998 Jun;10(6):479-84. doi: 10.1097/00042737-199806000-00008. PMID: 9855063

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...